Captivatingly, simultaneous overexpression of Survivin and oncogenic mycN generated tumors with shortened tumor latency, decreased apoptosis and displaying an increased frequency of structural chromosomal aberrations when compared to mycN-tumors. The gene discussed is MYCN; the disease is neoplasm.